CYDX (Cyduct Diagnostics) Shares Outstanding (Basic Average): 0.00 Mil (As of . 20)


What is Cyduct Diagnostics Shares Outstanding (Basic Average)?

Cyduct Diagnostics CYDX +4.22% Shares Outstanding (Basic Average) is 0.00 Mil as of . 20.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Cyduct Diagnostics's average basic shares outstanding for the quarter that ended in . 20 was 0.00 Mil.

Cyduct Diagnostics  (OTCPK:CYDX) Shares Outstanding (Basic Average) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Be Aware

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.

Cyduct Diagnostics Shares Outstanding (Basic Average) Related Terms

Cyduct Diagnostics Shares Outstanding (Basic Average) Historical Data

* Premium members only.

The historical data trend for Cyduct Diagnostics's Shares Outstanding (Basic Average) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cyduct Diagnostics Shares Outstanding (Basic Average) Chart

Cyduct Diagnostics Annual Data
Trend
Shares Outstanding (Basic Average)

Cyduct Diagnostics Quarterly Data
Shares Outstanding (Basic Average)

Cyduct Diagnostics Shares Outstanding (Basic Average) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that exact time point. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (Basic Average) of 0.00 Mil mean?
Cyduct Diagnostics (CYDX) has a Shares Outstanding (Basic Average) of 0.00 Mil as of . 20. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on Cyduct Diagnostics and its competitors.
Is Cyduct Diagnostics' Shares Outstanding (Basic Average) too high?
Cyduct Diagnostics' current Shares Outstanding (Basic Average) is 0.00 Mil.
How does Cyduct Diagnostics' Shares Outstanding (Basic Average) compare to SECI and QTXB?
Cyduct Diagnostics' Shares Outstanding (Basic Average) of 0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (Basic Average) for a Medical Devices & Instruments company?
A good Shares Outstanding (Basic Average) depends on the Medical Devices & Instruments industry context. However, Shares Outstanding (Basic Average) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (Basic Average) mean?
A high Shares Outstanding (Basic Average) can signal that a stock is expensive relative to its fundamentals. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on Cyduct Diagnostics and its competitors. Cyduct Diagnostics's current Shares Outstanding (Basic Average) is 0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cyduct Diagnostics stock overvalued right now?
Cyduct Diagnostics (CYDX) has a current Shares Outstanding (Basic Average) of 0.00 Mil. The current Shares Outstanding (Basic Average) is 0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (Basic Average) calculated?
Shares Outstanding (Basic Average) is calculated from a company's financial statements. For Cyduct Diagnostics (CYDX), the current Shares Outstanding (Basic Average) is 0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cyduct Diagnostics Business Description

Address 1698 Post Road East, Suite 1A, Westport, CT, USA, 06880
Cyduct Diagnostics Inc is a clinical-stage diagnostic company. It focuses on creating and enhancing a portfolio of technologies and assets based on the early assessment and detection of Breast Cancer. Its technology platform of MammoView devices is a single-use, high-margin product that assesses, screens, detects, monitors, and facilitates the treatment of identifiable changes that distinguish variations in breast health. The company markets these products under its Solos Endoscopy brand, along with a line of branded surgical instruments, manufactured by third parties to its design specifications, mainly endoscopes and hand-held surgical instruments for the minimally invasive surgery market.